Remote oncology monitoring that connects clinicians and cancer patients between visits.
Carevive is an oncology health technology company that gives care teams a remote patient monitoring platform to track symptoms, collect patient-reported outcomes, and manage cancer patients between clinic visits. The system is designed to surface actionable data for clinicians while reducing the burden on patients managing complex treatment regimens. On MarketScale, Carevive publishes content for oncology administrators, clinicians, and health systems evaluating remote care management tools.
Patient data, not claims data, transforms oncology care delivery
Carevive argues that real-world patient-reported outcomes, collected continuously during treatment, reveal what traditional big data cannot: how cancer patients actually experience disease and therapy in real time.
Carevive's core argument is that oncology improvement requires shifting from discrete, retrospective claims and clinical data to continuous, patient-reported experience data captured at the point of care. The channel demonstrates this through longitudinal case studies, registry analysis across 26 cancer types, and specific clinical workflows showing how alert-triggered interventions on symptom reports change care team behavior and patient adherence.
Drawn from Improving the Patient Experience in Cancer and 2 more →
“Big data is limited because its datapoints are discrete, providing only sequential snapshots without continuous assessment of patient experience on treatment.”
Carevive, Improving the Patient Experience in Cancer
By the numbers
What the channel argues
Who and what shows up
Dr. Aaron Galaznik
Chief Scientific Officer, Carevive
Led NSCLC webinar on smart data insights and hosted multiple discussions on PRO platform capabilities, alert systems, and longitudinal analysis in breast cancer and lung cancer populations.
John Elliot
VP of Sales, Carevive
Interviewed on OCM-to-EOM transition and revenue implications, representing commercial perspective on model shift.
Dr. Ethan Basch
Expert in electronic patient-reported outcomes (ePROs)
Led webinar discussion on digital remote monitoring challenges and best practices for implementing and optimizing ePRO data collection and engagement across cancer programs.
Tyler Kern
Host, Oncology and Technology
Conducted interviews with Carevive team on OCM-to-EOM transition and expectations for cancer care.
Michelle Dawn Mooney
Host, Technology and Oncology Podcast
Hosted discussion with John Elliot on revenue-enhancing opportunities and real-world impact of EOM transition.
Questions this channel answers
What makes Carevive's data different from traditional big data in oncology?
Carevive captures continuous, patient-reported experience at the point of care, not discrete clinical snapshots. Traditional big data provides sequential datapoints without continuous assessment of how patients actually experience treatment day to day.
Improving the Patient Experience in Cancer →How does PRO data improve clinical decision-making in real time?
The platform integrates patient-reported outcomes into care team workflows, uses alert triggers when patients report moderate to severe symptoms, and enables timely interventions on therapy adherence and symptom management, with studies showing reduced hospitalizations and ER visits.
Patient Engagement and Compliance →What are the revenue implications of moving from OCM to EOM?
EOM, effective July 1, 2023, replaces OCM and supports care for seven common cancer types with focus on health equity and accountable, affordable care, creating new revenue-enhancing opportunities for oncology practices.
The New Oncology Model Created to Improve Cancer Care →How can real-world oncology data inform drug development and clinical trials?
Carevive's real-time data from standard-of-care populations offers contemporary, FDA-relevant insights into patient-centered domains unlike historical trial data, which quickly becomes outdated. This bridges real-world outcomes with trial design and post-marketing assessment.
CV/COS Webinar: Applications and Future Directions →How engaged are cancer patients with continuous survey monitoring?
Patient compliance and persistence with survey follow-ups is impressive during the critical initial three months of treatment, the phase when care teams most need to monitor treatment experiences and intervene on adherence challenges.
Patient Engagement and Compliance →Best place to start
Carevive’s Longitudinal DataConcretely describes the dataset scale (1,700 patients, 26 cancer types, 600,000 data points) and why continuous patient-reported outcomes matter more than discrete snapshots.
Revenue Enhancing Opportunities: The Switch from OCM to EOMExplains the July 2023 policy change, what EOM supports, and why practices should act now to prepare for reimbursement and clinical workflow shifts.Industry context
Real-world evidence collection is expanding beyond post-approval studies into early-phase trial design. Continuous monitoring generates substantially more data points than traditional periodic assessments, reshaping how clinical evidence is gathered in drug development.
Latest media
Episodes
Follow the channel
Get new Carevive episodes in your inbox.
Subscribe to follow the conversation. We send a short note when new episodes and contributions go live.
Want a show like this for your brand?